カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

ペンニードルの世界市場予測（～2028）：種類別、長さ別、治療法別、購入形態別、エンドユーザー別

■ 英語タイトル：Pen Needles Market by Type (Standard Pen & Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase, End User, Unmet Needs, Key Stakeholders, Buying Criteria - Global Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：MD2851-23）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：MD2851-23
■ 発行日：2023年10月17日
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：249
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ペンニードルの世界市場予測（～2028）：種類別、長さ別、治療法別、購入形態別、エンドユーザー別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

"世界のペンニードル市場規模は2023年の16億米ドルから2028年には25億米ドルに達すると予測、予測期間中のCAGRは9.1%"バイオシミラー医薬品への嗜好の高まり、在宅環境への治療シフトの増加、安全なペンニードルに関する義務化は、市場の主要プレーヤーに幅広い成長機会を提供します。しかし、薬物送達の代替手段への嗜好、発展途上国における不十分な償還、注射針への不安が市場の成長を抑制しています。

"2022年のペンニードル市場において、購入形態別では市販薬セグメントが最大シェアを獲得"
購入形態に基づき、ペンニードル市場は処方箋ベース、市販、オンライン購入、その他の購入形態に区分されます。2022年の市場シェアは市販用が最大。店頭購入には、薬局、医療用品販売業者/供給業者などの店舗からの購入が含まれます。薬局による製品の現地配送、薬局、供給業者、流通業者による割引の提供は、この市場の成長を促進するいくつかの要因です。

"予測期間中、ペンニードル市場において設定別に最も高い成長率を目撃する在宅ケアセグメント"
ペンニードル市場はセッティングに基づき、家庭、病院＆クリニック、その他のセッティングにセグメント化されます。2022年のペンニードル市場で最大のシェアを占めたのは在宅ケアセグメントです。また、同セグメントは予測期間中に最も高いCAGRで成長する見込みです。インスリンペンニードルやペンニードルメーカーが提供する患者トレーニング、家庭用ペンニードルの採用増加などは、今後数年間の同セグメントの成長を支える要因の一部です。

"予測期間中、長さ別では4mmセグメントがペンニードル市場で最も急成長する見込み"
2022年のペンニードル市場では8mmセグメントが最大のシェアを占め、予測期間中は4mmセグメントが最も急成長するセグメントとなりそうです。4mm針の急成長は、針の長さの中で最も痛みが少ないことに起因しています。さらに、インスリン投与の効率も高いです。

"予測期間中に最も高いCAGRで成長するアジア太平洋市場"
ペンニードル市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカの5つの主要地域にセグメント化されています。様々な薬物投与方法に対する意識の高まり、ペンニードルの採用の増加、医療費の増加、可処分所得の増加、糖尿病の有病率の増加は、アジア太平洋地域におけるペンニードル市場の成長の主な要因の一部です。

供給側の一次インタビューの内訳
- 企業タイプ別：ティア1：22%、ティア2：36%、ティア3：42%
- 役職別 Cレベル：23%、Dレベル：28%、その他：49%
- 地域別 北米：40％、欧州：31％、APAC：25％、中南米：6％、中東・アフリカ：4%

ペンニードル市場で事業を展開している主要企業は、Novo Nordisk (Denmark), Embecta Corp. (US), Ypsomed Holding AG (Switzerland), and B. Braun Melsungen AG (Germany)です。

調査範囲
本レポートでは、ペンニードル市場を地域、タイプ、長さ、購入形態、設定、用途に基づいて調査しています。また、市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を調査し、市場リーダー向けに競争状況の詳細を提供しています。さらに、個々の成長動向に関してミクロ市場を分析し、主要5地域（およびこれらの地域のそれぞれの国）に関して市場セグメントの収益を予測しています。

レポート購入の主な利点
本レポートは、既存企業だけでなく、新規参入企業や小規模企業が市場の動向を把握するのに役立ちます。本レポートを購入される企業は、以下の5つの戦略を1つ、または組み合わせて使用することができます。

本レポートでは、以下のポイントについて考察しています：
- 市場促進要因：世界的な糖尿病有病率の増加と、特に先進国でのペンニードルの採用増加による市場成長について分析しています。
- 市場への浸透：ペンニードル市場におけるトップ企業の製品ポートフォリオに関する包括的な情報を提供します。本レポートでは、設定、地域、タイプ、購入形態、用途、長さに基づいて市場を分析します。
- 製品開発/イノベーション：ペンニードル市場における今後の技術、研究開発活動、製品発売に関する詳細な洞察を提供します。
- 市場開発：有利な新興市場に関する包括的情報。当レポートでは、各地域のペンニードル市場を分析しています。
- 市場の多様化：ペンニードル市場における製品、未開拓地域、最近の開発、投資に関する詳細な情報を提供します。
- 競争力の評価：ペンニードル市場における主要企業の市場シェア、戦略、製品、流通ネットワーク、製造能力などを詳細に評価しています。

1 イントロダクション
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 ペンニードルの世界市場：タイプ別
7 ペンニードルの世界市場：長さ別
8 ペンニードルの世界市場：用途別
9 ペンニードルの世界市場：セッティング別
10 ペンニードルの世界市場：購入形態別
11 ペンニードルの世界市場：地域別
12 競争状況
13 企業情報
14 付録

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS AND EXCLUSIONS 23
1.2.2 MARKET SEGMENTATION 25
1.2.3 YEARS CONSIDERED 26
1.3 CURRENCY CONSIDERED 26
TABLE 1 STANDARD CURRENCY CONVERSION RATES 26
1.4 LIMITATIONS 27
1.5 STAKEHOLDERS 27
1.6 SUMMARY OF CHANGES 27
1.7 RECESSION IMPACT 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 29
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
FIGURE 2 PRIMARY SOURCES 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Key industry insights 33
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY SETTING AND REGION 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34
2.2 MARKET SIZE ESTIMATION 34
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 35
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: EMBECTA CORP. (2022) 35
FIGURE 8 REVENUE ANALYSIS OF TOP FIVE COMPANIES: PEN NEEDLES MARKET (2022) 36
FIGURE 9 DEMAND-SIDE ANALYSIS 37
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 38
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 12 TOP-DOWN APPROACH 39
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 13 DATA TRIANGULATION METHODOLOGY 40
2.4 MARKET SHARE ANALYSIS 41
2.5 STUDY ASSUMPTIONS 41
2.6 RISK ASSESSMENT 41
TABLE 2 RISK ASSESSMENT ANALYSIS 41
2.7 METHODOLOGY-RELATED LIMITATIONS 41
2.8 RECESSION IMPACT ANALYSIS 42
3 EXECUTIVE SUMMARY 43
FIGURE 14 PEN NEEDLES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 43
FIGURE 15 PEN NEEDLES MARKET, BY LENGTH, 2023 VS. 2028 (USD MILLION) 44
FIGURE 16 PEN NEEDLES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 44
FIGURE 17 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2023 VS. 2028 (USD MILLION) 45
FIGURE 18 PEN NEEDLES MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION) 45
FIGURE 19 GEOGRAPHIC GROWTH OPPORTUNITIES 46
4 PREMIUM INSIGHTS 47
4.1 PEN NEEDLES MARKET OVERVIEW 47
FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD 47
4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH (2023) 48
FIGURE 21 5MM SEGMENT TO DOMINATE ASIA PACIFIC MARKET 48
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES 49
FIGURE 22 EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD 49
4.4 REGIONAL MIX 49
FIGURE 23 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
FIGURE 24 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.2.1 DRIVERS 51
5.2.1.1 Rising incidence of chronic diseases 51
FIGURE 25 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN US, 1995–2030 (MILLION INDIVIDUALS) 51
FIGURE 26 TYPE 1 DIABETIC POPULATION, BY COUNTRY (2022) 52
5.2.1.2 Favorable reimbursements in mature markets 52
5.2.1.3 Growing adoption of self-administration 53
5.2.1.4 Decreasing prices of insulin formulations 53
5.2.2 RESTRAINTS 54
5.2.2.1 Alternative methods of drug delivery 54
5.2.2.2 Poor reimbursements in emerging markets 54
5.2.2.3 Needle anxiety 54
5.2.3 OPPORTUNITIES 54
5.2.3.1 Growing preference for biosimilar drugs 54
5.2.3.2 High-growth potential of emerging economies 55
5.2.3.3 Rising healthcare expenditure on diabetes 55
5.2.3.4 Regulatory mandates for safety pen needles 56
5.2.4 CHALLENGES 56
5.2.4.1 Reuse of pen needles 56
5.2.4.2 Misuse of injection pens 56
5.3 REIMBURSEMENT SCENARIO 57
TABLE 3 REIMBURSEMENT OF PEN NEEDLES, BY COUNTRY 57
5.4 PRICING ANALYSIS 59
5.4.1 AVERAGE SELLING PRICE FOR PEN NEEDLES, BY TYPE 59
TABLE 4 PRICING OF PEN NEEDLES, BY KEY PLAYERS 59
FIGURE 27 AVERAGE SELLING PRICE OF PEN NEEDLES, BY TYPE 60
5.4.2 AVERAGE SELLING PRICE TRENDS 61
5.5 VALUE CHAIN ANALYSIS 61
FIGURE 28 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS 61
5.6 ECOSYSTEM/MARKET MAP 62
FIGURE 29 PEN NEEDLES MARKET: ECOSYSTEM/MARKET MAP 62
5.7 PORTER’S FIVE FORCES ANALYSIS 63
TABLE 5 PEN NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS 63
5.7.1 INTENSITY OF COMPETITIVE RIVALRY 63
5.7.2 BARGAINING POWER OF SUPPLIERS 63
5.7.3 BARGAINING POWER OF BUYERS 63
5.7.4 THREAT OF SUBSTITUTES 64
5.7.5 THREAT OF NEW ENTRANTS 64
5.8 SUPPLY CHAIN ANALYSIS 65
FIGURE 30 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS 66
5.9 REGULATORY ANALYSIS 66
5.9.1 NORTH AMERICA 66
5.9.1.1 US 66
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION 66
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 66
5.9.1.2 Canada 67
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
FIGURE 31 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS 67
5.9.2 EUROPE 68
FIGURE 32 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES 68
5.9.3 ASIA PACIFIC 68
5.9.3.1 Japan 68
TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 69
5.9.3.2 China 69
TABLE 10 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL 69
TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES 70
5.9.3.3 India 70
5.9.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
5.10 HS CODES: PEN INJECTORS 74
5.11 PATENT ANALYSIS 74
5.11.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES 74
FIGURE 33 PATENT PUBLICATION TRENDS (JANUARY 2013–SEPTEMBER 2023) 74
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANTS ANALYSIS 75
FIGURE 34 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLE PATENTS (JANUARY 2013–SEPTEMBER 2023) 75
FIGURE 35 TOP APPLICANT COUNTRIES FOR PEN NEEDLE PATENTS (JANUARY 2013– SEPTEMBER 2023) 76
TABLE 16 PEN INJECTORS MARKET: MAJOR PATENTS 77
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 78
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 78
FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES 78
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES 78
5.12.2 BUYING CRITERIA 78
FIGURE 37 KEY BUYING CRITERIA FOR PEN NEEDLES, BY TYPE 78
TABLE 18 KEY BUYING CRITERIA FOR PEN NEEDLES 79
5.13 CASE STUDY ANALYSIS 79
TABLE 19 CONTRIBUTION OF SMART INSULIN PENS FOR DIABETES MANAGEMENT 79
5.14 TECHNOLOGY ANALYSIS 79
5.14.1 KEY TECHNOLOGY 79
5.14.1.1 Fluid flow enhancement technology 79
5.14.2 COMPLEMENTARY TECHNOLOGY 80
5.14.2.1 Microfabricated needles 80
5.14.2.2 AI in pen injectors 80
5.14.3 ADJACENT TECHNOLOGY 81
5.14.3.1 Autoinjectors 81
5.15 KEY CONFERENCES AND EVENTS 81
TABLE 20 PEN NEEDLES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023−2024) 81
5.16 ADJACENT MARKETS ANALYSIS 82
FIGURE 38 PEN NEEDLES MARKET: ADJACENT MARKETS 82
5.17 USER REQUIREMENTS IN PEN NEEDLES MARKET 83
6 PEN NEEDLES MARKET, BY TYPE 84
6.1 INTRODUCTION 85
TABLE 21 PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 85
TABLE 22 PEN NEEDLES MARKET, BY REGION, 2021–2028 (MILLION UNITS) 85
6.2 STANDARD PEN NEEDLES 85
6.2.1 GROWING PREFERENCE DUE TO LOW COSTS TO DRIVE MARKET 85
TABLE 23 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS 86
TABLE 24 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 25 STANDARD PEN NEEDLES MARKET, BY REGION, 2021–2028 (MILLION UNITS) 87
6.3 SAFETY PEN NEEDLES 88
6.3.1 CONCERNS ASSOCIATED WITH NEEDLESTICK INJURIES TO PROPEL MARKET 88
TABLE 26 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS 88
TABLE 27 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 28 SAFETY PEN NEEDLES MARKET, BY REGION, 2021–2028 (MILLION UNITS) 89
7 PEN NEEDLES MARKET, BY LENGTH 90
7.1 INTRODUCTION 91
TABLE 29 PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 91
7.2 8MM 91
7.2.1 WIDE ADOPTION IN NORTH AMERICA TO BOOST DEMAND 91
TABLE 30 8MM PEN NEEDLES OFFERED BY KEY PLAYERS 91
TABLE 31 8MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
7.3 5MM 93
7.3.1 SHORTER LENGTH TO FUEL UPTAKE 93
TABLE 32 5MM PEN NEEDLES OFFERED BY KEY PLAYERS 93
TABLE 33 5MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
7.4 6MM 95
7.4.1 FAVORABLE REIMBURSEMENTS TO BOOST DEMAND 95
TABLE 34 6MM PEN NEEDLES OFFERED BY KEY PLAYERS 95
TABLE 35 6MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
7.5 4MM 96
7.5.1 WIDE ADOPTION AMONG CHILDREN FOR INSULIN DELIVERY TO DRIVE DEMAND 96
TABLE 36 4MM PEN NEEDLES OFFERED BY KEY PLAYERS 96
TABLE 37 4MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
7.6 12MM 98
7.6.1 HIGH UTILIZATION OF SHORTER NEEDLES TO LIMIT ADOPTION 98
TABLE 38 12MM PEN NEEDLES OFFERED BY KEY PLAYERS 98
TABLE 39 12MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
7.7 10MM 99
7.7.1 PAINFUL ADMINISTRATION TO RESTRAIN ADOPTION 99
TABLE 40 10MM PEN NEEDLES OFFERED BY KEY PLAYERS 99
TABLE 41 10MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
8 PEN NEEDLES MARKET, BY APPLICATION 101
8.1 INTRODUCTION 102
TABLE 42 PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 102
8.2 INSULIN THERAPY 102
8.2.1 RISING INCIDENCE OF DIABETES TO PROPEL MARKET 102
TABLE 43 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 103
8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY (GLP-1 THERAPY) 103
8.3.1 GROWING FOCUS OF PHARMA COMPANIES ON GLP-1-BASED THERAPIES TO DRIVE MARKET 103
TABLE 44 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 104
8.4 GROWTH HORMONE THERAPY 105
8.4.1 RECURRING REQUIREMENT OF INJECTIONS TO RESTRAIN MARKET 105
TABLE 45 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 106
8.5 OSTEOPOROSIS 106
8.5.1 RISING VITAMIN D DEFICIENCY CASES TO PROPEL MARKET 106
TABLE 46 PEN NEEDLES MARKET FOR OSTEOPOROSIS, BY COUNTRY, 2021–2028 (USD MILLION) 107
8.6 OTHER APPLICATIONS 107
TABLE 47 PEN NEEDLES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 108
9 PEN NEEDLES MARKET, BY SETTING 109
9.1 INTRODUCTION 110
TABLE 48 PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 110
9.2 HOME CARE SETTINGS 110
9.2.1 GROWING PREFERENCE FOR SELF-ADMINISTRATION OF INSULIN TO PROPEL MARKET 110
TABLE 49 PEN NEEDLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 111
9.3 HOSPITALS AND CLINICS 111
9.3.1 INCREASING ADOPTION OF SAFETY PEN NEEDLES TO DRIVE MARKET 111
TABLE 50 PEN NEEDLES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 112
 
9.4 OTHER SETTINGS 113
TABLE 51 PEN NEEDLES MARKET FOR OTHER SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 113
10 PEN NEEDLES MARKET, BY MODE OF PURCHASE 114
10.1 INTRODUCTION 115
TABLE 52 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 115
10.2 PRESCRIPTION-BASED PURCHASE 115
10.2.1 RETAIL PURCHASES TO SUPPORT MARKET GROWTH 115
TABLE 53 PEN NEEDLES MARKET FOR PRESCRIPTION-BASED PURCHASE, BY COUNTRY, 2021–2028 (USD MILLION) 116
10.3 OVER-THE-COUNTER PURCHASE 116
10.3.1 DISCOUNTS OFFERED BY LOCAL PHARMACIES, SUPPLIERS, AND DISTRIBUTORS TO DRIVE MARKET 116
TABLE 54 PEN NEEDLES MARKET FOR OVER-THE-COUNTER PURCHASE, BY COUNTRY, 2021–2028 (USD MILLION) 117
10.4 ONLINE PURCHASE 117
10.4.1 CONVENIENT TIME-EFFICIENT BENEFITS TO PROPEL MARKET 117
TABLE 55 PEN NEEDLES MARKET FOR ONLINE PURCHASES, BY COUNTRY, 2021–2028 (USD MILLION) 118
10.5 OTHER MODES OF PURCHASE 119
TABLE 56 PEN NEEDLES MARKET FOR OTHER MODES OF PURCHASE, BY COUNTRY, 2021–2028 (USD MILLION) 120
11 PEN NEEDLES MARKET, BY REGION 121
11.1 INTRODUCTION 122
TABLE 57 PEN NEEDLES MARKET, BY REGION, 2021–2028 (USD MILLION) 122
FIGURE 39 EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD 123
11.2 NORTH AMERICA 123
FIGURE 40 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT 124
TABLE 58 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 59 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 60 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 125
TABLE 61 NORTH AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 125
TABLE 62 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 126
TABLE 63 NORTH AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 126
11.2.1 US 126
11.2.1.1 Favorable reimbursements to propel market 126
FIGURE 41 TOTAL FERTILITY RATE IN US POPULATION (1990−2021) 127
TABLE 64 US: MACROECONOMIC INDICATORS 128
TABLE 65 US: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 66 US: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 129
TABLE 67 US: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 68 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 129
TABLE 69 US: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 130
11.2.2 CANADA 130
11.2.2.1 Rising prevalence of diabetes to drive market 130
TABLE 70 CANADA: MACROECONOMIC INDICATORS 131
TABLE 71 CANADA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 72 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 132
TABLE 73 CANADA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 132
TABLE 74 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 132
TABLE 75 CANADA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 133
11.2.3 NORTH AMERICA: RECESSION IMPACT 133
11.3 EUROPE 133
TABLE 76 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 77 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 78 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 134
TABLE 79 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 135
TABLE 80 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 135
TABLE 81 EUROPE: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 135
11.3.1 GERMANY 136
11.3.1.1 High healthcare spending to propel market 136
TABLE 82 GERMANY: MACROECONOMIC INDICATORS 136
TABLE 83 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 84 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 137
TABLE 85 GERMANY: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 86 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 138
TABLE 87 GERMANY: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 138
11.3.2 UK 138
11.3.2.1 NHS support and growing access to cost-effective pen needles to drive market 138
TABLE 88 UK: MACROECONOMIC INDICATORS 139
TABLE 89 UK: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 90 UK: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 139
TABLE 91 UK: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 140
TABLE 92 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 140
TABLE 93 UK: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 140
11.3.3 FRANCE 141
11.3.3.1 Favorable health insurance system to propel market 141
TABLE 94 FRANCE: MACROECONOMIC INDICATORS 141
TABLE 95 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 96 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 142
TABLE 97 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 98 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 143
TABLE 99 FRANCE: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 143
11.3.4 ITALY 143
11.3.4.1 Low product pricing to support market growth 143
TABLE 100 ITALY: MACROECONOMIC INDICATORS 144
TABLE 101 ITALY: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 102 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 145
TABLE 103 ITALY: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 104 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 145
TABLE 105 ITALY: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 146
11.3.5 SPAIN 146
11.3.5.1 Supportive regulations mandating the use of safety pen needles to propel market 146
TABLE 106 SPAIN: MACROECONOMIC INDICATORS 147
TABLE 107 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 108 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 148
TABLE 109 SPAIN: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 110 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 148
TABLE 111 SPAIN: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 149
11.3.6 REST OF EUROPE 149
TABLE 112 REST OF EUROPE: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 113 REST OF EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 150
TABLE 114 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 115 REST OF EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 151
TABLE 116 REST OF EUROPE: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 151
11.3.7 EUROPE: RECESSION IMPACT 151
11.4 ASIA PACIFIC 152
FIGURE 42 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT 152
TABLE 117 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 118 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 119 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 153
TABLE 120 ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 121 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 154
TABLE 122 ASIA PACIFIC: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 154
11.4.1 JAPAN 155
11.4.1.1 Supportive reimbursement policies and universal healthcare coverage to propel market 155
TABLE 123 JAPAN: MACROECONOMIC INDICATORS 155
TABLE 124 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 125 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 156
TABLE 126 JAPAN: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 156
TABLE 127 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 157
TABLE 128 JAPAN: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 157
11.4.2 CHINA 157
11.4.2.1 Large patient population and healthcare infrastructure improvements to drive market growth 157
TABLE 129 CHINA: MACROECONOMIC INDICATORS 158
TABLE 130 CHINA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 131 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 159
TABLE 132 CHINA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 159
TABLE 133 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 159
TABLE 134 CHINA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 160
11.4.3 AUSTRALIA & NEW ZEALAND 160
11.4.3.1 High healthcare expenditure to support market growth 160
TABLE 135 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 136 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 161
TABLE 137 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 138 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 161
TABLE 139 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 162
11.4.4 INDIA 162
11.4.4.1 Healthcare infrastructural improvements and rising disease burden to propel market 162
TABLE 140 INDIA: MACROECONOMIC INDICATORS 162
TABLE 141 INDIA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 142 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 163
TABLE 143 INDIA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 144 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 164
TABLE 145 INDIA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 164
11.4.5 SOUTH KOREA 164
11.4.5.1 Rising incidence of obesity and hypertension to support market growth 164
TABLE 146 SOUTH KOREA: MACROECONOMIC INDICATORS 165
TABLE 147 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 148 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 165
TABLE 149 SOUTH KOREA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 150 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 166
TABLE 151 SOUTH KOREA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 166
11.4.6 SOUTHEAST ASIA 167
11.4.6.1 Growing awareness about diabetes to propel market 167
FIGURE 43 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2021 VS. 2030) 167
FIGURE 44 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2020) 167
FIGURE 45 ELDERLY POPULATION IN SOUTHEAST ASIA (2022) 168
TABLE 152 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 153 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 168
TABLE 154 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169
TABLE 155 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 169
TABLE 156 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 169
11.4.7 REST OF ASIA PACIFIC 170
TABLE 157 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 158 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 170
TABLE 159 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 160 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 171
TABLE 161 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 171
11.4.8 ASIA PACIFIC: RECESSION IMPACT 172
11.5 LATIN AMERICA 172
TABLE 162 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 163 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 164 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 173
TABLE 165 LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 166 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 174
TABLE 167 LATIN AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 174
11.5.1 BRAZIL 174
11.5.1.1 Growing adoption of safety pen needles to drive market 174
TABLE 168 BRAZIL: MACROECONOMIC INDICATORS 175
TABLE 169 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 170 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 175
TABLE 171 BRAZIL: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 172 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 176
TABLE 173 BRAZIL: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 176
11.5.2 MEXICO 177
11.5.2.1 Low coverage for core health services to restrain market 177
TABLE 174 MEXICO: MACROECONOMIC INDICATORS 177
TABLE 175 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 176 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 178
TABLE 177 MEXICO: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 178 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 178
TABLE 179 MEXICO: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 179
11.5.3 ARGENTINA 179
11.5.3.1 High out-of-pocket expenditure on insulin products to restrain market 179
TABLE 180 ARGENTINA: MACROECONOMIC INDICATORS 179
TABLE 181 ARGENTINA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 182 ARGENTINA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 180
TABLE 183 ARGENTINA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180
TABLE 184 ARGENTINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 181
TABLE 185 ARGENTINA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 181
11.5.4 REST OF LATIN AMERICA 181
FIGURE 46 HEALTH EXPENDITURE OF COUNTRIES IN LATIN AMERICA FOR 2020 (% GDP) 182
TABLE 186 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 187 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 182
TABLE 188 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 183
TABLE 189 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 183
TABLE 190 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 183
11.5.5 LATIN AMERICA: RECESSION IMPACT 184
11.6 MIDDLE EAST & AFRICA 184
11.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY TO SUPPORT MARKET GROWTH 184
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 184
TABLE 191 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 192 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION) 185
TABLE 193 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 194 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION) 186
TABLE 195 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION) 186
12 COMPETITIVE LANDSCAPE 187
12.1 OVERVIEW 187
12.2 KEY PLAYER STRATEGIES 187
TABLE 196 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PEN NEEDLES MARKET 187
12.3 REVENUE SHARE ANALYSIS 188
FIGURE 47 REVENUE ANALYSIS FOR KEY COMPANIES IN LAST FIVE YEARS 188
12.4 MARKET SHARE ANALYSIS 188
FIGURE 48 PEN NEEDLES MARKET SHARE, BY KEY PLAYER (2022) 189
12.5 COMPANY EVALUATION MATRIX (2022) 190
12.5.1 STARS 190
12.5.2 EMERGING LEADERS 190
12.5.3 PERVASIVE PLAYERS 190
12.5.4 PARTICIPANTS 190
FIGURE 49 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (2022) 191
12.5.5 COMPANY FOOTPRINT 191
TABLE 197 PEN NEEDLES MARKET: OVERALL COMPANY FOOTPRINT (20 COMPANIES) 192
TABLE 198 PEN NEEDLES MARKET: TYPE FOOTPRINT (20 COMPANIES) 193
TABLE 199 PEN NEEDLES MARKET: LENGTH FOOTPRINT (20 COMPANIES) 194
TABLE 200 PEN NEEDLES MARKET: APPLICATION FOOTPRINT (20 COMPANIES) 195
TABLE 201 PEN NEEDLES MARKET: REGIONAL FOOTPRINT (20 COMPANIES) 196
12.6 START-UP/SME EVALUATION MATRIX (2022) 197
12.6.1 PROGRESSIVE COMPANIES 197
12.6.2 RESPONSIVE COMPANIES 197
12.6.3 DYNAMIC COMPANIES 197
12.6.4 STARTING BLOCKS 197
FIGURE 50 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS (2022) 198
12.6.5 COMPETITIVE BENCHMARKING 199
TABLE 202 PEN NEEDLES MARKET: DETAILED LIST OF KEY START-UPS/SMES 199
12.7 COMPETITIVE SCENARIOS AND TRENDS 200
12.7.1 PRODUCT LAUNCHES 200
TABLE 203 PEN NEEDLES MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–OCTOBER 2023) 200
12.7.2 DEALS 200
TABLE 204 PEN NEEDLES MARKET: DEALS (JANUARY 2020– OCTOBER 2023) 200
12.7.3 OTHER DEVELOPMENTS 201
TABLE 205 PEN NEEDLES MARKET: OTHER DEVELOPMENTS (JANUARY 2020– OCTOBER 2023) 201
13 COMPANY PROFILES 202
(Business overview, Products offered, Recent developments & MnM View)*
13.1 KEY PLAYERS 202
13.1.1 EMBECTA CORP. (PART OF BD) 202
TABLE 206 EMBECTA CORP.: COMPANY OVERVIEW 202
FIGURE 51 EMBECTA CORP.: COMPANY SNAPSHOT (2022) 203
13.1.2 NOVO NORDISK A/S 206
TABLE 207 NOVO NORDISK A/S: COMPANY OVERVIEW 206
FIGURE 52 NOVO NORDISK A/S: COMPANY SNAPSHOT (2022) 207
13.1.3 YPSOMED AG 209
TABLE 208 YPSOMED AG: COMPANY OVERVIEW 209
FIGURE 53 YPSOMED AG: COMPANY SNAPSHOT (2022) 210
13.1.4 B. BRAUN MELSUNGEN AG 212
TABLE 209 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 212
FIGURE 54 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) 213
13.1.5 TERUMO CORPORATION 215
TABLE 210 TERUMO CORPORATION: COMPANY OVERVIEW 215
FIGURE 55 TERUMO CORPORATION: COMPANY SNAPSHOT (2022) 216
13.1.6 NIPRO CORPORATION 218
TABLE 211 NIPRO CORPORATION: COMPANY OVERVIEW 218
FIGURE 56 NIPRO CORPORATION: COMPANY SNAPSHOT (2022) 219
13.1.7 OWEN MUMFORD 221
TABLE 212 OWEN MUMFORD: BUSINESS OVERVIEW 221
13.1.8 ARKRAY, INC. 223
TABLE 213 ARKRAY: BUSINESS OVERVIEW 223
13.1.9 ULTIMED, INC. 225
TABLE 214 ULTIMED, INC.: BUSINESS OVERVIEW 225
13.1.10 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD. 226
TABLE 215 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: BUSINESS OVERVIEW 226
13.1.11 MONTMED, INC. 227
TABLE 216 MONTMED, INC.: BUSINESS OVERVIEW 227
13.1.12 HTL-STREFA 228
TABLE 217 HTL-STREFA: BUSINESS OVERVIEW 228
13.1.13 ALLISON MEDICAL, INC. 229
TABLE 218 ALLISON MEDICAL, INC.: BUSINESS OVERVIEW 229
13.1.14 GLUCORX LIMITED 230
TABLE 219 GLUCORX LIMITED: BUSINESS OVERVIEW 230
13.1.15 BERPU MEDICAL TECHNOLOGY CO., LTD. 231
TABLE 220 BERPU MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 231
13.1.16 ADVACARE PHARMA 232
TABLE 221 ADVACARE PHARMA: BUSINESS OVERVIEW 232
13.1.17 ARTSANA GROUP 233
TABLE 222 ARTSANA GROUP: BUSINESS OVERVIEW 233
13.1.18 PROMISEMED MEDICAL DEVICES INC. 234
TABLE 223 PROMISEMED MEDICAL DEVICES INC.: BUSINESS OVERVIEW 234
13.1.19 TRIVIDIA HEALTH, INC. 235
TABLE 224 TRIVIDIA HEALTH, INC.: BUSINESS OVERVIEW 235
13.1.20 VOGT MEDICAL VERTRIEB GMBH 236
TABLE 225 VOGT MEDICAL VERTRIEB GMBH: BUSINESS OVERVIEW 236
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS 237
13.2.1 VAN HEEK MEDICAL 237
TABLE 226 VAN HEEK MEDICAL: COMPANY OVERVIEW 237
13.2.2 SIMPLE DIAGNOSTICS 238
TABLE 227 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW 238
13.2.3 IYON MEDICAL 239
TABLE 228 IYON MEDICAL: COMPANY OVERVIEW 239
13.2.4 LINKS MEDICAL PRODUCTS, INC. 240
TABLE 229 LINKS MEDICAL PRODUCTS, INC.: COMPANY OVERVIEW 240
13.2.5 MHC MEDICAL PRODUCTS, LLC 240
TABLE 230 MHC MEDICAL PRODUCTS: COMPANY OVERVIEW 240
14 APPENDIX 241
14.1 DISCUSSION GUIDE 241
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 245
14.3 CUSTOMIZATION OPTIONS 247
14.4 RELATED REPORTS 247
14.5 AUTHOR DETAILS 248



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 急性腎不全治療の世界市場2022～2031：治療法別、エンドユーザー別
  • 慢性腎臓病治療の世界市場2023年～2030年：治療法別、エンドユーザー別、地域別
  • 急性肺損傷治療の世界市場（2022～2031）：治療法別、エンドユーザー別
  • 動脈硬化治療薬の世界市場2023年～2030年：ステージ別、診断別、治療法別、投与経路別、エンドユーザー別、流通チャネル別、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MD2851-23 )"ペンニードルの世界市場予測（～2028）：種類別、長さ別、治療法別、購入形態別、エンドユーザー別" (英文：Pen Needles Market by Type (Standard Pen & Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase, End User, Unmet Needs, Key Stakeholders, Buying Criteria - Global Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。